Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 17/20 | 0.36 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22106778 | 0.94 | CRHR1 (0.39) | CRHR1CYP3A4 | |
| SCHEMBL20733330 | 0.74 | CRHR1 (0.48) | CRHR1 | |
| SCHEMBL7218557 | 0.72 | CRHR1 (0.40) | CRHR1ALDH1A1TSHR | |
| SCHEMBL21886230 | 0.70 | CRHR1 (0.45) | CRHR1 | |
| SCHEMBL20733328 | 0.70 | CRHR1 (0.51) | CRHR1 | |
| SCHEMBL21886138 | 0.70 | LMNA (0.43) | CRHR1KDM4EALDH1A1CYP3A4HPGD | |
| SCHEMBL7534790 | 0.69 | CRHR1 (0.47) | CRHR1 | |
| SCHEMBL21886229 | 0.69 | LMNA (0.36) | CRHR1ALDH1A1 | |
| SCHEMBL8202018 | 0.64 | CRHR1 (0.56) | CRHR1 | |
| SCHEMBL21886137 | 0.63 | CRHR1 (0.52) | CRHR1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844071-B2 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200190094-A1 | TRIAZOLOPYRIDINES AND TRIAZOLOPYRIMIDINES THAT LOWER STRESS-INDUCED P-TAU | BUCK INSTITUTE FOR RESEARCH ON AGING | 2020-06-18 | — | — | US | disclosed |
| US-10618899-B2 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2020-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844071-B2 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | MAPT, PSEN1, PSEN2 | CRHR1 36/4885TNF 1699/4885PDE4D 555/4885 |
| US-20200190094-A1 | TRIAZOLOPYRIDINES AND TRIAZOLOPYRIMIDINES THAT LOWER STRESS-INDUCED P-TAU | MAPT, PYGB, PSEN1 | CRHR1 92/4885TNF 2038/4885PDE4D 78/4885 |
| US-10618899-B2 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | MAPT, PSEN1, PSEN2 | CRHR1 44/4885TNF 2719/4885PDE4D 442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.